Effectiveness of HCC Treatments

Treatment strategies for HCC are evolving rapidly, with immunotherapy combinations showing promising results in large phase 3 clinical trials. However, effectiveness in clinical practice can differ from efficacy in trials given differences in patient populations, provider expertise, and protocols. We have participated in real-world data and meta-analyses to evaluate their effectiveness and safety in clinical practice. This research is important to refine treatment pathways and assess long-term outcomes across diverse patient populations.